RESUMEN
OBJECTIVES: To develop evidence-based European League Against Rheumatism (EULAR) recommendations for vaccination in patients with autoimmune inflammatory rheumatic diseases (AIIRD). METHODS: A EULAR task force was composed of experts representing 11 European countries, consisting of eight rheumatologists, four clinical immunologists, one rheumatologist/clinical immunologist, one infectious disease physician, one nephrologist, one paediatrician/rheumatologist and one clinical epidemiologist. Key questions were formulated and the eligible spectrum of AIIRD, immunosuppressive drugs and vaccines were defined in order to perform a systematic literature review. A search was made of Medline from 1966 to October 2009 as well as abstracts from the EULAR meetings of 2008 and 2009 and the American College of Rheumatology (ACR) meetings of 2007 and 2008. Evidence was graded in categories I-IV, the strength of recommendations was graded in categories A-D and Delphi voting was applied to determine the level of agreement between the experts of the task force. RESULTS: Eight key questions and 13 recommendations addressing vaccination in patients with AIIRD were formulated. The strength of each recommendation was determined. Delphi voting revealed a very high level of agreement with the recommendations among the experts of the task force. Finally, a research agenda was proposed. CONCLUSION: Recommendations for vaccination in patients with AIIRD based on the currently available evidence and expert opinion were formulated. More research is needed, particularly regarding the incidence of vaccine-preventable infectious diseases and the safety of vaccination in patients with AIIRD.
Asunto(s)
Enfermedades Autoinmunes/complicaciones , Infecciones Oportunistas/complicaciones , Infecciones Oportunistas/prevención & control , Enfermedades Reumáticas/complicaciones , Vacunación , Enfermedades Autoinmunes/tratamiento farmacológico , Técnica Delphi , Medicina Basada en la Evidencia/métodos , Humanos , Inmunosupresores/efectos adversos , Enfermedades Reumáticas/tratamiento farmacológicoRESUMEN
OBJECTIVES: To present the systematic literature review (SLR), which formed the basis for the European League Against Rheumatism (EULAR) evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases (AIIRD). METHODS: AIIRD, vaccines and immunomodulating drugs, as well as eight key questions were defined by the multidisciplinary expert committee commissioned by EULAR for developing the recommendations. A SLR was performed using MedLine through October 2009 and including data from meta-analyses, systematic reviews, randomized trials, and observational studies, excluding case series with ≤ 5 participants. Articles in English and regarding patients ≥ 16 years of age, were eligible. RESULTS: Several vaccine-preventable infections (VPI) occur more often in AIIRD-patients and most vaccines are efficacious in AIIRD-patients, even when treated with immunomodulating agents, except rituximab. There does not appear to be an increase in vaccination-related harms in vaccinated patients with AIIRD in comparison with unvaccinated patients with AIIRD. However, these studies are underpowered and therefore not conclusive. CONCLUSION: Based on the current evidence from the literature, recommendations for vaccination in patients with AIIRD were made. However, more research is needed in particular regarding incidence of VPI, harms of vaccination and the influence of (new and established) immunomodulating agents on vaccination efficacy.
Asunto(s)
Enfermedades Autoinmunes/complicaciones , Medicina Basada en la Evidencia , Infecciones Oportunistas/complicaciones , Infecciones Oportunistas/prevención & control , Enfermedades Reumáticas/complicaciones , Vacunación , Adulto , Antirreumáticos/uso terapéutico , Enfermedades Autoinmunes/tratamiento farmacológico , Susceptibilidad a Enfermedades/inducido químicamente , Susceptibilidad a Enfermedades/complicaciones , Humanos , Inmunización Secundaria/estadística & datos numéricos , Factores Inmunológicos/uso terapéutico , Enfermedades Reumáticas/tratamiento farmacológico , Vacunación/economía , Vacunación/estadística & datos numéricos , Vacunas/administración & dosificación , Vacunas/efectos adversos , Vacunas/normasRESUMEN
A case of Behçet's syndrome in a 32-year-old woman occurring shortly after her third vaccination against typhoid fever is described. Scleritis and pyoderma gangrenosum were unusual manifestations of BS that occurred in this case. Treatment benefit was provided by mycophenolate mofetil and etanercept. As bacterial antigens have been proposed as potential triggers for the onset of BS, it is possible that the syndrome was precipitated by typhoid vaccination in this patient.